| Trial ID: | L0987 |
| Source ID: | NCT00063232
|
| Associated Drug: |
Metformin
|
| Title: |
Treatment of Nonalcoholic Steatohepatitis With Metformin
|
| Acronym: |
--
|
| Status: |
Not recruiting
|
| Study Results: |
Has Results
|
| Results: |
https://clinicaltrials.gov/ct2/show/results/NCT00063232
|
| Conditions: |
Hepatitis;Hepatitis;Hepatitis;Hepatitis
|
| Interventions: |
Drug: Metformin;Drug: Metformin;Drug: Metformin;Drug: Metformin
|
| Outcome Measures: |
Change in the Histological NASH Activity Index at 48 Weeks Compared With Baseline (Number of Participants in Each Change Category);Change in the Histological NASH Activity Index at 48 Weeks Compared With Baseline (Number of Participants in Each Change Category)Change in Serum Alanine Aminotransferase (ALT) Levels From Baseline (Number of Participants in Each Change Category);Change in Insulin Sensitivity (Glucose Tolerance, Homeostatic Model Assessment of Insulin Resistence (HOMA-IR)) From Baseline
|
| Sponsor/Collaborators: |
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
|
| Gender: |
All
|
| Age: |
18 Yearsnan
|
| Phases: |
Phase 2
|
| Enrollment: |
28
|
| Study Type: |
Interventional
|
| Study Designs: |
--
|
| Start Date: |
23/06/2003
|
| Completion Date: |
--
|
| Results First Posted: |
20/07/2011
|
| Last Update Posted: |
19 October 2017
|
| Locations: |
United States;United States;United States;United States
|
| URL: |
https://clinicaltrials.gov/show/NCT00063232
|
